<p>GE HealthCare Technologies（納斯達克：GEHC - 獲取免費報告）在週二發佈的研究報告中，阿根廷證券公司的研究人員將其目標價格從 95.00 美元下調至 80.00 美元，MarketScreener 報道。該公司目前對該股票給予 “買入” 評級。阿根廷的價格目標暗示該股票當前價格有 28.92% 的潛在上漲空間。</p>
<ul>
<li>GE 航空：卡塔爾交易推動數十億美元的增長引擎</li>
</ul>
<p>其他幾家股票研究分析師也對 GEHC 發佈了報告。摩根大通將 GE HealthCare Technologies 的目標價格從 80.00 美元下調至 65.00 美元，並在 4 月 30 日的研究報告中對該公司給予 “中性” 評級。瑞穗證券在 4 月 30 日的研究報告中將 GE HealthCare Technologies 的目標價格從 90.00 美元下調至 80.00 美元。巴黎銀行 Exane 在 5 月 1 日的研究報告中將 GE HealthCare Technologies 的目標價格從 95.00 美元下調至 88.00 美元。Evercore 在 4 月 30 日的研究報告中對 GE HealthCare Technologies 設定了 80.00 美元的目標價格。最後，巴克萊在 4 月 30 日的研究報告中將 GE HealthCare Technologies 的目標價格從 87.00 美元下調至 78.00 美元，並對該股票給予 “等權重” 評級。九位研究分析師對該股票給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，GE HealthCare Technologies 的平均評級為 “持有”，平均目標價格為 80.63 美元。</p>
<p><strong>獲取我們關於 GEHC 的最新報告</strong></p>
<h2>GE HealthCare Technologies 股票上漲 0.9%</h2>
<ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
<p>在週二的交易中，GEHC 上漲 0.54 美元，達到 62.05 美元。該公司股票的交易量為 1,765,974 股，而其平均交易量為 4,147,691 股。該股票的市值為 282.3 億美元，市盈率為 14.89，市盈增長比率為 1.37，貝塔值為 0.74。該公司的 50 日移動平均線為 69.27 美元，200 日移動平均線為 76.59 美元。GE HealthCare Technologies 的 52 周低點為 58.75 美元，52 周高點為 89.77 美元。該公司的速動比率為 0.95，流動比率為 1.22，債務與股本比率為 0.95。</p>
<p>GE HealthCare Technologies（納斯達克：GEHC - 獲取免費報告）最後一次發佈財報是在 4 月 29 日，週三。該公司報告季度每股收益為 0.99 美元，低於分析師一致預期的 1.07 美元，差距為 0.08 美元。該公司在本季度的收入為 51.3 億美元，而分析師預期為 50.4 億美元。GE HealthCare Technologies 的股本回報率為 20.46%，淨利潤率為 9.10%。該公司的收入同比增長 7.4%。在去年同期，該公司每股收益為 1.01 美元。GE HealthCare Technologies 已將其 2026 財年的指導目標設定為 4.800-5.000 美元每股收益。整體來看，股票分析師預計 GE HealthCare Technologies 在當前財年將發佈 4.89 美元的每股收益。</p>
<h2>GE HealthCare Technologies 的內部買賣情況</h2>
<ul>
<li>超聲波減肥：GE HealthCare 和諾和諾德的合作</li>
</ul>
<p>在其他新聞中，內部人士 Frank R. Jimenez 在 4 月 30 日的交易中購買了 1,750 股該公司的股票。股票的平均購買價格為每股 60.45 美元，總價值為 105,787.50 美元。購買後，該內部人士持有 93,932 股公司股票，價值約為 5,678,189.40 美元。這筆交易代表其持股比例增加了 1.90%。該購買在 SEC 的法律文件中披露，相關信息可在 SEC 網站上找到。此外，董事 Rodney F. Hochman 在 5 月 12 日的交易中購買了 1,618 股該股票。股票的平均購買價格為每股 62.03 美元，總交易額為 100,364.54 美元。交易完成後，該董事在公司持有 1,618 股，價值約為 100,364.54 美元。這代表其持股比例的∞增長。該購買的 SEC 文件提供了更多信息。在過去的一個季度中，內部人士購買了 11,847 股公司股票，價值 719,555 美元。公司內部人士持有該公司股票的 0.36%。</p>
<h2>對 GE HealthCare Technologies 的對沖基金看法</h2>
<p>機構投資者和對沖基金最近買賣了該公司的股票。Laurel Wealth Advisors LLC 在第四季度購買了 GE HealthCare Technologies 的新頭寸，價值約 26,000 美元。Optima Capital LLC 在第四季度收購了 GE HealthCare Technologies 的新頭寸，價值約 27,000 美元。Godfrey Financial Associates Inc.在第四季度收購了 GE HealthCare Technologies 的新股份，價值約 27,000 美元。Montag A &amp; Associates Inc.在第四季度將其在 GE HealthCare Technologies 的持股增加了 105.4%。Montag A &amp; Associates Inc.現在持有 341 股該公司的股票，價值 28,000 美元，此前在上個季度又購買了 175 股。最後，Transamerica Financial Advisors LLC 在第四季度將其在 GE HealthCare Technologies 的持股增加了 331.6%。Transamerica Financial Advisors LLC 現在持有 341 股該公司的股票，價值 28,000 美元，此前在上個季度又收購了 262 股。對沖基金和其他機構投資者持有該公司 82.06% 的股票。</p>
<h2>GE HealthCare Technologies 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>GE HealthCare Technologies 納斯達克股票代碼：GEHC 是一家全球醫療技術和診斷公司，開發、製造並銷售廣泛的產品和服務，服務於醫療提供者。其產品組合以診斷成像系統為中心，包括 MRI、CT、PET 和 X 射線設備，以及超聲設備。該公司還提供患者監測和麻醉輸送系統、介入和外科成像解決方案，以及用於臨牀護理和研究環境的分子成像技術。</p>
<p>除了硬件，GE HealthCare 還提供旨在改善臨牀工作流程和設備正常運行時間的軟件、分析和生命週期服務。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比 GE HealthCare Technologies 更好的股票</li>
<li>Nebius Group 在強勁收益後被下調評級，股價回落 9%</li>
<li>重塑人工智能：NextEra Energy 引發大規模合併</li>
<li>切換開關：福特會是下一個大能源股票嗎？</li>
<li>Nano Nuclear Energy 的新交易是否提升了前景？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
<p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 GE HealthCare Technologies 並不在名單上。</p>
<p>雖然 GE HealthCare Technologies 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

GEHC

美國醫藥設備 ETF - iShares

標普健康醫療設備 ETF - SPDR

<p>阿根廷分析師將 GE HealthCare Technologies（NASDAQ:GEHC）的目標股價從 95.00 美元下調至 80.00 美元，維持 “買入” 評級。摩根大通和瑞穗等其他公司也調整了他們的目標價，摩根大通將其設定為 65.00 美元。目前，GEHC 的股票交易價格為 62.05 美元，分析師的平均目標價為 80.63 美元。該公司報告每股收益為 0.99 美元，未達到預期，但收入同比增長了 7.4%</p>

<p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) had its target price lowered by equities researchers at Argus from $95.00 to $80.00 in a research note issued on Tuesday,MarketScreener reports. The firm presently has a &#34;buy&#34; rating on the stock. Argus' price objective would suggest a potential upside of 28.92% from the stock's current price.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（納斯達克：GEHC - 獲取免費報告）在週二發佈的研究報告中，阿根廷證券公司的研究人員將其目標價格從 95.00 美元下調至 80.00 美元，MarketScreener 報道。該公司目前對該股票給予 “買入” 評級。阿根廷的價格目標暗示該股票當前價格有 28.92% 的潛在上漲空間。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空：卡塔爾交易推動數十億美元的增長引擎</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on GEHC. JPMorgan Chase &amp; Co. cut their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a &#34;neutral&#34; rating for the company in a research note on Thursday, April 30th. Mizuho reduced their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Evercore set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Barclays dropped their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an &#34;equal weight&#34; rating on the stock in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of &#34;Hold&#34; and an average price target of $80.63.</p>
<div class="lb-trans"><p>其他幾家股票研究分析師也對 GEHC 發佈了報告。摩根大通將 GE HealthCare Technologies 的目標價格從 80.00 美元下調至 65.00 美元，並在 4 月 30 日的研究報告中對該公司給予 “中性” 評級。瑞穗證券在 4 月 30 日的研究報告中將 GE HealthCare Technologies 的目標價格從 90.00 美元下調至 80.00 美元。巴黎銀行 Exane 在 5 月 1 日的研究報告中將 GE HealthCare Technologies 的目標價格從 95.00 美元下調至 88.00 美元。Evercore 在 4 月 30 日的研究報告中對 GE HealthCare Technologies 設定了 80.00 美元的目標價格。最後，巴克萊在 4 月 30 日的研究報告中將 GE HealthCare Technologies 的目標價格從 87.00 美元下調至 78.00 美元，並對該股票給予 “等權重” 評級。九位研究分析師對該股票給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，GE HealthCare Technologies 的平均評級為 “持有”，平均目標價格為 80.63 美元。</p>
</div><p><strong>Get Our Latest Report on GEHC</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 GEHC 的最新報告</strong></p>
</div><h2>GE HealthCare Technologies Stock Up 0.9%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上漲 0.9%</h2>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韋爾的拆分：HON 股票對投資者來説是個好交易嗎？</li>
</ul>
</div><p>GEHC traded up $0.54 during trading on Tuesday, hitting $62.05. 1,765,974 shares of the company's stock were exchanged, compared to its average volume of 4,147,691. The stock has a market cap of $28.23 billion, a P/E ratio of 14.89, a PEG ratio of 1.37 and a beta of 0.74. The business's 50 day moving average is $69.27 and its two-hundred day moving average is $76.59. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.</p>
<div class="lb-trans"><p>在週二的交易中，GEHC 上漲 0.54 美元，達到 62.05 美元。該公司股票的交易量為 1,765,974 股，而其平均交易量為 4,147,691 股。該股票的市值為 282.3 億美元，市盈率為 14.89，市盈增長比率為 1.37，貝塔值為 0.74。該公司的 50 日移動平均線為 69.27 美元，200 日移動平均線為 76.59 美元。GE HealthCare Technologies 的 52 周低點為 58.75 美元，52 周高點為 89.77 美元。該公司的速動比率為 0.95，流動比率為 1.22，債務與股本比率為 0.95。</p>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts expect that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（納斯達克：GEHC - 獲取免費報告）最後一次發佈財報是在 4 月 29 日，週三。該公司報告季度每股收益為 0.99 美元，低於分析師一致預期的 1.07 美元，差距為 0.08 美元。該公司在本季度的收入為 51.3 億美元，而分析師預期為 50.4 億美元。GE HealthCare Technologies 的股本回報率為 20.46%，淨利潤率為 9.10%。該公司的收入同比增長 7.4%。在去年同期，該公司每股收益為 1.01 美元。GE HealthCare Technologies 已將其 2026 財年的指導目標設定為 4.800-5.000 美元每股收益。整體來看，股票分析師預計 GE HealthCare Technologies 在當前財年將發佈 4.89 美元的每股收益。</p>
</div><h2>Insider Buying and Selling at GE HealthCare Technologies</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 的內部買賣情況</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超聲波減肥：GE HealthCare 和諾和諾德的合作</li>
</ul>
</div><p>In other news, insider Frank R. Jimenez acquired 1,750 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider owned 93,932 shares of the company's stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 11,847 shares of company stock valued at $719,555. Corporate insiders own 0.36% of the company's stock.</p>
<div class="lb-trans"><p>在其他新聞中，內部人士 Frank R. Jimenez 在 4 月 30 日的交易中購買了 1,750 股該公司的股票。股票的平均購買價格為每股 60.45 美元，總價值為 105,787.50 美元。購買後，該內部人士持有 93,932 股公司股票，價值約為 5,678,189.40 美元。這筆交易代表其持股比例增加了 1.90%。該購買在 SEC 的法律文件中披露，相關信息可在 SEC 網站上找到。此外，董事 Rodney F. Hochman 在 5 月 12 日的交易中購買了 1,618 股該股票。股票的平均購買價格為每股 62.03 美元，總交易額為 100,364.54 美元。交易完成後，該董事在公司持有 1,618 股，價值約為 100,364.54 美元。這代表其持股比例的∞增長。該購買的 SEC 文件提供了更多信息。在過去的一個季度中，內部人士購買了 11,847 股公司股票，價值 719,555 美元。公司內部人士持有該公司股票的 0.36%。</p>
</div><h2>Hedge Funds Weigh In On GE HealthCare Technologies</h2>
<div class="lb-trans"><h2>對 GE HealthCare Technologies 的對沖基金看法</h2>
</div><p>Institutional investors and hedge funds have recently bought and sold shares of the business. Laurel Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $26,000. Optima Capital LLC acquired a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Montag A &amp; Associates Inc. increased its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A &amp; Associates Inc. now owns 341 shares of the company's stock worth $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC raised its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock worth $28,000 after acquiring an additional 262 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近買賣了該公司的股票。Laurel Wealth Advisors LLC 在第四季度購買了 GE HealthCare Technologies 的新頭寸，價值約 26,000 美元。Optima Capital LLC 在第四季度收購了 GE HealthCare Technologies 的新頭寸，價值約 27,000 美元。Godfrey Financial Associates Inc.在第四季度收購了 GE HealthCare Technologies 的新股份，價值約 27,000 美元。Montag A &amp; Associates Inc.在第四季度將其在 GE HealthCare Technologies 的持股增加了 105.4%。Montag A &amp; Associates Inc.現在持有 341 股該公司的股票，價值 28,000 美元，此前在上個季度又購買了 175 股。最後，Transamerica Financial Advisors LLC 在第四季度將其在 GE HealthCare Technologies 的持股增加了 331.6%。Transamerica Financial Advisors LLC 現在持有 341 股該公司的股票，價值 28,000 美元，此前在上個季度又收購了 262 股。對沖基金和其他機構投資者持有該公司 82.06% 的股票。</p>
</div><h2>GE HealthCare Technologies Company Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.</p>
<div class="lb-trans"><p>GE HealthCare Technologies 納斯達克股票代碼：GEHC 是一家全球醫療技術和診斷公司，開發、製造並銷售廣泛的產品和服務，服務於醫療提供者。其產品組合以診斷成像系統為中心，包括 MRI、CT、PET 和 X 射線設備，以及超聲設備。該公司還提供患者監測和麻醉輸送系統、介入和外科成像解決方案，以及用於臨牀護理和研究環境的分子成像技術。</p>
</div><p>In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.</p>
<div class="lb-trans"><p>除了硬件，GE HealthCare 還提供旨在改善臨牀工作流程和設備正常運行時間的軟件、分析和生命週期服務。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings</li>
<li>Rewiring AI: NextEra Energy Sparks a Mega Merger</li>
<li>Flipping the Switch: Is Ford the Next Big Energy Stock?</li>
<li>Does Nano Nuclear Energy’s New Deal Amp the Outlook?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 GE HealthCare Technologies 更好的股票</li>
<li>Nebius Group 在強勁收益後被下調評級，股價回落 9%</li>
<li>重塑人工智能：NextEra Energy 引發大規模合併</li>
<li>切換開關：福特會是下一個大能源股票嗎？</li>
<li>Nano Nuclear Energy 的新交易是否提升了前景？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 GE HealthCare Technologies 嗎？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 GE HealthCare Technologies 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 GE HealthCare Technologies 並不在名單上。</p>
</div><p>While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 GE HealthCare Technologies 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

GE HealthCare Technologies (NASDAQ:GEHC) Price Target Cut to $80.00 by Analysts at Argus

Market Beat

GE HealthCare Tech

摩根大通

瑞穗金融集團

Mizuho Financial Group, Inc.

法國巴黎銀行(ADR)

Evercore

巴克萊銀行

GE航空航天

霍尼韋爾

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Honeywell International - WI

Argus 的分析師將 GE HealthCare Technologies（NASDAQ:GEHC）的目標股價下調至 80.00 美元